1 year return (CAGR)
21.43%
Pieris Pharmaceuticals Inc Exchange (NASDAQ, USD)
PIRS
-
-2.53 (-15.69%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-62.29%
5 year return (CAGR)
-45.45%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
17.96M
Price/Sales
13.28
Ent value
2.85M
Price/Book
1.10
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-11.57%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 15.01 |
| Daily high | 15.35 |
| Daily low | 13.26 |
| Daily Volume | 52K |
| 1y analyst estimate | 7.00 |
| Beta | 0.66 |
| EPS (TTM) | -12.09 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PIRS | S&P500 | |
| Current price drop from All-time high | -98.20% | -0.59% |
| Highest price drop | -99.14% | -56.47% |
| Date of highest drop | 11 Jul 2024 | 9 Mar 2009 |
| Avg drop from high | -61.75% | -10.68% |
| Avg time to new high | 58 days | 12 days |
| Max time to new high | 1721 days | 1805 days |
News
No items found